Altered thalamic subregion functional networks in patients with treatment-resistant schizophrenia

Table 1 Demographic and clinical characteristics of patients with treatment-resistant schizophrenia and healthy controls

Characteristics	TRS (n = 50)	HCs (n = 61)	P value
Age (yr)	42.64 (9.79)	39.89 (9.52)	0.137
Sex
Male (%)	32 (64%)	29 (48%)	0.083
Female (%)	18 (36%)	32 (52%)
Education (years)	13.53 (2.27)	13.33 (1.92)	0.613
Duration of illness (mo)	215.22 (110.09)	-	-
PANSS
Positive symptoms	15.96 (4.99)	-	-
Negative symptoms	16.00 (7.30)	-	-
General psychopathology	28.40 (7.74)	-	-
Total	60.36 (17.52)	-	-
SOFAS	49.00 (8.81)	-	-
Medication
Chlorpromazine equivalent (mg/d)	915.33 (411.41)	-	-

Data given as mean (SD). HCs: Healthy controls; PANSS: Positive and Negative Syndrome Scale; SOFAS: Social and Occupational Functioning Assessment Scale; TRS: Treatment Resistant Schizophrenia.